Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.

Journal:

Circulation

Published:

2025-08-06

DOI:

10.1161/circulationaha.125.073610

Affiliations:

7

Authors:

11

Go to article

Institutions	Authors	Share
Tufts Medical Center, United States of America (USA)	5.000000	0.45
University of Virginia (UVA), United States of America (USA)	3.000000	0.27
Tufts University, United States of America (USA)	2.000000	0.18
Hansjorg Wyss Institute for Biologically Inspired Engineering, United States of America (USA)	0.500000	0.05
Boston University (BU), United States of America (USA)	0.500000	0.05

Interested in Cardiovascular Medicine and Haematology?